Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin anticoagulation for liver fibrosis after liver transplantation for hepatitis C
2006-006221-77Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of warfarin in hepatic fibrosis, Cirrhosis and hepatitis C virus infection (2 arms), sponsored by Imperial College London. Primary endpoint: Stage of liver fibrosis on liver biopsy after two years. Started May 2007; status: completed.
02
Drugs
warfarin
03
Conditions
hepatic fibrosisCirrhosishepatitis C virus infection
Beyond the preview
Go deeper on 2006-006221-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006221-77.